Patient Guide: A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 5 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06353971
Status: TERMINATED
Condition: Urticaria, Chronic Inducible Urticaria
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 5 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Berlin,
  • Dresden,
  • Lübeck,
  • • And 2 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily